Home » Depomed, New River Enter Into Development and License Agreement
Depomed, New River Enter Into Development and License Agreement
Depomed announced that it has entered into a development and license agreement with New River Pharmaceuticals to create pharmaceutical products using Depomed's patented oral drug delivery technology with New River's drug compounds.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050606005434&newsLang=en)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May